Company Analysis

Arcturus Therapeutics Holdings Inc. (ARCT)

Nasdaq: ARCT · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2019
Grade5.3
◀ Past 5.7● Present 6.2▶ Future 3.9
1 est.

Who runs Arcturus Therapeutics Holdings Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Payne Joseph E
President and CEO. First filing Aug 2019, latest Dec 19, 2025, 3 filings in all.
Officers reporting now
6
of 13 people with a filing in the last fifteen months
Directors reporting now
7
17 people on the record since 2019
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Mulroy DennisChief Financial OfficerMay 2026May 7, 2026none
Payne Joseph EPresident and CEOAug 2019Dec 19, 2025none
Chivukula PadChief Scientific Officer & COOFeb 2020Dec 19, 2025none
Kurata LanceChief Legal OfficerAug 2020Dec 19, 2025none
Roberts JosephControllerDec 2025Dec 19, 2025none
Sassine AndyChief Financial OfficerAug 2019Aug 20, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Barlow James FdirectorOct 2019Jun 15, 2026none
Farrell Peter CdirectorAug 2019Jun 15, 2026none
Holmes Edward WdirectorSep 2019Jun 15, 2026none
Marantz Jing L.directorDec 2021Jun 15, 2026none
Markels JohndirectorDec 2022Jun 15, 2026none
Marquet MagdadirectorSep 2019Jun 15, 2026none
Slaoui MoncefdirectorJun 2024Jun 15, 2026none
Earlier names on the record4, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ARCT · research, not advice